952138-12-4

Usage

Uses

Used in Medicinal Chemistry:
1,6-Naphthyridin-4(1H)-one, 7-chlorois used as a building block for the synthesis of biologically active compounds due to its unique structure and properties.
Used in Drug Development:
1,6-Naphthyridin-4(1H)-one, 7-chlorois used as a candidate in medicinal chemistry for the development of novel pharmaceuticals for the treatment of various diseases.

Upstream product

• 2587-02-2 2,6-dichloro-[4]pyridylamine 
• 863785-65-3 5-[[(2,6-dichloropyridin-4-yl)amino]methylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 1018812-97-9 5-[[(2-chloropyridin-4-yl)amino]methylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 863785-66-4 5,7-dichloro-1H-1,6-naphthyridin-4-one 

Downstream Products

• 952138-13-5 4,7-dichloro-1,6-naphthyridine 
• 952138-14-6 tert-butyl 2-[4-(7-chloro-1,6-naphthyridin-4-yloxy)-2-methoxyphenyl]acetate 
• 952138-11-3 2-[4-(7-chloro-1,6-naphthyridin-4-yloxy)-2-methoxyphenyl]acetic acid 

Relevant academic research and scientific papers

PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF

The present invention discloses a pyrido-azacyclic compound represented by formula I, an isomer thereof, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, a preparation process thereof and a composition comprising the compound, and a use thereof as a multi-target protein kinase inhibitor in the preparation of a medicament for the treatment of diseases that are associated with protein kinase, especially c-Met, such as cancer and the like. The compound represented by formula I has potent inhibitory activity on tumor cells with overexpression of c-Met kinase, can effectively target c-Met-mediated signaling pathway, and can be used in the treatment of diseases such as cancer and the like that is caused by the overexpression of c-Met kinase.

Strategic studies in the syntheses of novel 6,7-substituted quinolones and 7- or 6-substituted 1,6- and 1,7-naphthyridones

This paper describes the different strategies devised and applied to overcome the selectivity issues in the syntheses of 6,7-disubstituted-1H-quinolin-4-one, 7-substituted-1H-1,6-naphthyridin-4-one and 6-substituted-1H-1,7-naphthyridin-4-one derivatives. They allowed us to improve the overall yields and the scaling-up feasibility. Several examples illustrate these strategies with their advantages and drawbacks.

NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS

The invention concerns naphthyridine derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.